This inventor holds 3 USPTO granted patents. Top assignees: Sandoz Pharmaceuticals Corp., Sandoz Pharm. Corp.. Active years: 1990-1992.
Company Filing History:
Years Active: 1990-1992
Title: Seung H Cheon: Innovator in Pharmaceutical Chemistry
Introduction
Seung H Cheon is a notable inventor based in Glen Ridge, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds three patents that focus on innovative compounds with potential therapeutic applications.
Latest Patents
Among his latest patents, Cheon has developed 5-aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno pyridines. These compounds are disclosed as useful PAF receptor antagonists and for treating tumors. The inventions include pharmaceutical compositions containing these compounds as active ingredients, along with methods for using such compositions to inhibit PAF-mediated bronchoconstriction and extravasation. They also aim to control hyperreactive airways, protect against endotoxin-induced hypotension and death, and treat tumors.
Career Highlights
Cheon has worked with prominent companies in the pharmaceutical industry, including Sandoz Pharmaceuticals Corp. and Sandoz Pharm. Corp. His work has significantly contributed to advancements in drug development and therapeutic solutions.
Collaborations
One of his notable collaborators is William J Houlihan, with whom he has worked on various projects in the field of pharmaceutical research.
Conclusion
Seung H Cheon is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of various medical conditions. His innovative patents reflect his commitment to improving healthcare through scientific research and development.